Journal articleJ Clin Oncol2019

Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer.

DOI 10.1200/jco.19.00730 ↗ OpenAlex, retrieved 5 November 2026

Journal: J Clin Oncol
Published: 9 August 2019
Citations: 161
Type: Article

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Trials 1

Builds on itDose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas NCT02037230 ↗

Grants 4

Administrative Supplement P30 Cancer Center Support Grant (CCSG): Phase 1 Study of Olaparib in Combination with Durvalu… P30CA046592 ↗
Translational Research in GI Cancer P50CA130810 ↗
Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer R01CA138723 ↗
Sensitization to Chemoradiation by Therapeutic Targeting of the DNA Damage Response U01CA216449 ↗